Maria Jose Godoy Calderon, PhD, is Research Assistant Professor in the Department of Medicine at the University of Illinois College of Medicine Chicago in the lab of University of Illinois Cancer Center Deputy Director VK Gadi, MD, PhD. She was awarded a 2023 Illinois Cancer Health Equity Research (I-CHER) Center $30,000 pilot grant for her “Surface-engineered NK/Trastuzumab Cells as a Targeted Immunotherapy for HER2-low Breast Cancer.” Calderon’s project was about evaluating a novel immunotherapy for HER2-low breast cancer based on surface-engineered NK cells linked to trastuzumab (SE-NK/Tz cells). The project aims to address the health disparity challenge around cell-based cancer immunotherapies for breast cancer. Considering its low cost, easy and fast method of preparation, this investigational therapy could be widely administered to HER2-low breast cancer patients unable to access other conventional cell-based therapies.
Maria Jose Godoy Calderon, PhD
Research Assistant Professor
Medicine
Medicine
Research Program
Translational Oncology Program (TO)
Email: [email protected]
